MARKET

XTLB

XTLB

Xtl Biopharmaceu
NASDAQ
1.225
0.000
0.00%
After Hours: 1.230 +0.005 +0.38% 17:42 12/02 EST
OPEN
1.225
PREV CLOSE
1.225
HIGH
1.225
LOW
1.225
VOLUME
105
TURNOVER
0
52 WEEK HIGH
3.300
52 WEEK LOW
0.8503
MARKET CAP
6.68M
P/E (TTM)
17.51
1D
5D
1M
3M
1Y
5Y
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.
Benzinga · 09/29 09:09
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers
Benzinga · 09/28 18:43
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
Gainers
Benzinga · 09/28 16:40
12 Health Care Stocks Moving In Monday's Intraday Session
 
Benzinga · 09/19 18:25
LIFE, TBLT and XTLB among pre market gainers
Super Micro Computer (SMCI) +20% <a href="https://seekingalpha.com/ne...
Seekingalpha · 07/21 12:31
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Benzinga · 05/17 12:09
G Medical, ChemoCentryx top healthcare gainers; Denali, Immix among losers
Gainers: G Medical Innovations (NASDAQ:GMVD) +20%. ChemoCentryx (NASDAQ:CCXI) +12%. Homology Medicines (NASDAQ:FIXX) +8%. Babylon Holdings (NYSE:BBLN) +7%. XTL Biopharmaceuticals (NASDAQ:XTLB) +7%. Losers: Denali Therapeutics Inc. (NASDAQ:DNLI) -13%. Immix...
Seekingalpha · 01/13 15:02
Triple-S Management, Bio-Path leads healthcare gainers; Theravance Biopharma, Vivos Therapeutics among major losers
Gainers: Triple-S Management (NYSE:GTS) +45%, Bio-Path (NASDAQ:BPTH) +21%, Reviva Pharmaceuticals (NASDAQ:RVPH) +21%, XTL Biopharmaceuticals (NASDAQ:XTLB) +13%, Protara Therapeutics (NASDAQ:TARA) +12%. Losers: Theravance Biopharma (NASDAQ:TBPH) -31%, Vivos...
Seekingalpha · 08/24/2021 15:10
More
About XTLB
XTL Biopharmaceuticals Ltd is a biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The Company pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren’s syndrome (SS). hCDR1 is a peptide (short protein) that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong the survival of patients for the treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by the kidney. EPO stimulates erythropoiesis, the production of red blood cells, by binding to its receptor on the surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.

Webull offers kinds of X T L Biopharmaceuticals Ltd (ADR) stock information, including NASDAQ:XTLB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTLB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XTLB stock methods without spending real money on the virtual paper trading platform.